Aims: To compare the effect of fasting period duration on complication rates in neonates managed conservatively for necrotizing enterocolitis (NEC) Bell stage II. Methods: We conducted a multicenter study to analyze retrospectively multiple data collected by standardized questionnaire on all admissions for NEC between January 2000 and December 2006. NEC was staged using modified Bell criteria. We divided the conservatively managed neonates with NEC Bell stage II into two groups (those fasted for -5 days and those fasted for )5 days) and compared the complication rates. Results: Of the 47 conservatively managed neonates Bell stage II, 30 (64%) fasted for -5 days (range 1-4 days) and 17 (36%) for )5 days (range 6-16 days). There were no significant differences for any of the patient characteristics analyzed. One (3%) and four (24%) neonates, respectively, developed post-NEC bowel stricture. One (3%) and two neonates (12%) suffered NEC relapse. None and five (29%) neonates developed catheter-related sepsis. Conclusion: Shorter fasting after NEC appears to lower morbidity after the acute phase of the disease. In particular, shorter-fasted neonates have significantly less catheter-related sepsis. We found no benefit in longer fasting.
Introduction
Necrotizing enterocolitis (NEC) is the most common acquired intraabdominal emergency in infants w10x and the most common surgical emergency in the neonatal intensive care unit (NICU) w11x. Incidences range from 3% to 28%, averaging 6%-10% in infants with birth weights -1500 g, and incurring a mortality of 10%-30% w7x. Although the precise cause remains unclear, incriminated factors include impaired immunity of the immature gut, enteral feeding, and bacterial gut colonization, although no specific pathogen has been identified w12, 16x.
Treatment of sonographically and radiologically confirmed NEC consists of nasogastric decompression, antibiotic therapy, total parenteral nutrition (TPN), and surgery when necessary. There is no standard recommendation for when to reinitiate enteral feeding in nonsurgically treated infants. Textbooks recommend resting the bowel for 7-10 days w3, 7x. However, the scientific basis for relatively prolonged fasting is unclear w13x. The issue of fasting period duration is particularly important in a NICU such as ours that manages most of its NEC cases conservatively. We therefore conducted a multicenter comparison of fasting period duration in conservatively managed NEC Bell stage II to determine its effect on complications such as bowel stricture, NEC relapse, and catheter-related sepsis.
Patients and methods
We conducted a retrospective analysis of all term and preterm neonates with NEC (ns124) admitted to five Swiss NICUs between January 2000 and December 2006. All NICUs were tertiary centers, well equipped for managing sick neonates with pediatric surgical support. We used data collected by standardized questionnaire. Three NICU questionnaires were filled out by the same person in the study group and the other two by a NICU neonatologist. The questionnaires incorporated the international definition of NEC and the Bell stages w2x. They covered the following items: fasting period duration (some NICUs followed a fixed 5-day regime, others a fixed 10-day regime, but all often tailored the period according to their individual experience wfasting period range: 4-14 daysx and modified Bell criteria w8x); gestational age; birth weight; sex; antenatal steroids; cause of prematurity; umbilical catheterization; patent ductus arterio- Since conservatively managed neonates in Bell stage II were our primary focus, we subdivided the infants concerned into those fasted for -5 days and those fasted for )5 days to permit comparison of complication rates, primarily bowel stricture, NEC relapse, and catheter-related sepsis. We chose the 5-day cutoff because it was half the duration of the longest standard regime (10 days) in any NICU. We focused on neonates in Bell stage II, because the criteria of Bell stage I (suspected NEC) are quite vague, with the potential for inconsistent reporting and classification. We also excluded Bell stage III neonates because all required surgery.
After different fasting periods in the individual NICUs, the same feeding algorithm was implemented. It comprised 10 mL/kg body weight (BW) solution by gastric tube in 12 or 8 portions/d on day 1 (D1), 10 mL/kg BW breast milk or formula milk on D2, increasing by 20 mL/kg BW/d to 140-150 mL/kg BW/d.
Statistical analysis: we analyzed normally distributed continuous variables using the unpaired t-test and categorical variables using Fisher's exact test.
Results
The total population of 124 infants with Bell stage I-III NEC included five term and 119 preterm neonates (-32 weeks, ns89; G32 weeks, ns30). Over the 7-year study period, the five NICUs admitted 2005 inborn preterm neonates aged -32 weeks, giving an incidence of NEC of 4.4% in this age group. Treatment was conser- fasted for -5 days (range 1-5 days; NICU1 ns28, NICU2 ns2, NICU3-5 ns0) and 17 (36%) for )5 days (range 6-16 days; NICU1 ns3, NICU2 ns7, NICU3 ns4, NICU4 ns3, NICU5 ns0). All were preterm except for two and one neonates, respectively. Characteristics of the groups did not differ (Table 2 ) except for ''blood in stool'', which was less frequent in neonates with fasting period )5 days (Ps0.0003). Ages at NEC symptom onset (mean, SD) were 8.6"7.8 and 9.4"9.0 days (Ps0.74). TPN was administered for 14.9"4.0 and 18.5"5.9 days (Ps0.02). Neonates in the -5 days group needed 14.9"4.0 (range 8-25) days of fasting until initiation of full enteral nutrition vs. 18.5"5.9 (range 10-36) days needed by those in the )5 days group (Ps0.02).
Complications (Table 3)
None and five neonates (29%; NICU1 ns1, NICU2 ns2, NICU3 ns2, NICU4/5 ns0) developed catheter-related sepsis, a single episode in all cases (Ps0.004). Blood cultures yielded coagulase-negative Staphylococcus (ns5). One (3%) and four neonates (24%) required surgery for early post-NEC stricture (Ps0.05); all had evidence of ileus with vomiting, abdominal distension, and confirmatory radiology. One (3%) and two neonates (12%) relapsed (Ps0.27), with symptom onset ranging from 3 to 4 weeks after the initial episode; one was treated conservatively, the other two surgically. Stricture and relapse rates tended to be lower in the shorter-fasted group. No neonate developed short bowel syndrome and none died.
Discussion
Despite many studies of enteral feeding before the onset of NEC w18x, data are lacking on the timing of enteral refeeding after NEC, hence the absence of consensus guidelines. A 1975 report associated relapse in ''several patients'' with the reintroduction of enteral feeding -10 days after NEC w8x. Textbooks offer the unsubstantiated recommendation to rest the bowel for 7-10 days w3, 7x. However, a 2003 study concluded that early enteral feeding after NEC was associated with significant benefits and no apparent adverse effects w5x. Early refeeding may have a healing effect or, at least, helps recovery of the intestinal mucosa. Local trophic nutrients support and stimulate mucosal growth and may thus be protective. In contrast, in the absence of enteral feeding, mucosal villous atrophy may occur within one week, predisposing to recurrent intestinal injury and feeding intolerance w4, 12x.
Our analysis of five Swiss neonatal units mirrors the variability in the literature over post-NEC re-feeding. Although each unit practices the same re-feeding regime, they differ in their belief as to when re-feeding should start, in particular, in conservatively managed stage II NEC. Whereas one unit has already managed to significantly shorten the fasting period, the other units, despite the same severity of NEC, are still equivocal over the introduction of advanced re-feeding. Individual experience is still much too often at work. This raises the questions: When is the right time to re-feed in stage II NEC and are long fasting periods actually counterproductive?
Our retrospective study shows that early enteral feeding in conservatively managed NEC stage II is associated with less catheter-related sepsis, which may be related to the shorter requirement for TPN, but our data also reveal no adverse effects of shorter fasting. On the contrary, the rates of bowel stricture (3% vs. 24%) showed only borderline significance and relapse (3% vs. 12%) tended to be lower than in longer-fasted neonates. Assuming an NEC relapse rate of roughly 6% (for conservatively managed neonates) in this study, 356 patients would be required per treatment arm to have a modest chance of detecting a doubling of the NEC relapse rate (80% power, at 0.05 significance level). With only 17 patients in one of the treatment arms, this study was underpowered for detecting this clinically important outcome (it was only powered to detect a difference in relapse rates of 6% vs. 45%).
Early stricture, within the neonatal period, is quite a common complication of NEC. It occurs in conservatively managed neonates as well as in those treated surgically, and is presumably due to post-ischemic scarring w1x. Treatment is always surgical. No specific (including bacteriological) criteria have succeeded in predicting which patients are at risk of stricture after conservative management w6x. The incidences in our study, namely 3% and 24%, were somewhat lower than the 16%-37% reported in the literature w6, 19x.
The incidence of NEC in our overall population of preterm neonates -32 weeks, 4.4%, was within the reported range w3, 7, 12x. Similarly, our relapse rates in conservatively managed neonates, 3% and 12%, were also consistent with the literature w3, 9x despite potential inconsistencies in reporting this parameter: The five NICUs differed in their interpretation of certain signs (e.g., blood in the stool), and did not always classify them as relapse.
Despite our study's limitations, e.g., its retrospective design, our observations suggest that early enteral feeding after conservatively managed NEC stage II may lower morbidity after the acute phase of the disease. In particular, neonates fasting for a shorter period had significantly less catheter-related sepsis. We failed to identify any benefit in longer fasting.
